Search

You searched for "lesions"

2417 results found

Clinical outcomes of endoscopic dacryocystorhinostomy

5 April 2022 | | EYE - Paediatrics, EYE - Strabismus
The aim of this study was to report the authors’ experience with endoscopic dacryocystorhinostomy (ED) in a paediatric population and to evaluate the effect of surgical site reassessment on anatomy and clinical outcomes. The study included 47 children <18 years...

Review of the use of amniotic membrane in restrictive strabismus

3 October 2022 | | EYE - Paediatrics, EYE - Strabismus
This literature review was undertaken to investigate the indications, complications and final results of amniotic membrane (AM) transplantation in ocular motility restrictions. The review (of 1103 papers) outlines the healing process plus use of AM. Excluded papers were those of...

Does paediatric uveitis reactivate after treatment with anti-TNF-a drugs?

1 June 2015 | | EYE - Vitreo-Retinal
As a potentially blinding disease that can affect 7-27/100000 children, uveitis remains a rare condition, where little evidence based data is available to guide management decisions. Most paediatric uveitis cases are chronic, anterior and non-infectious and may be associated with...

Report: National Student Ophthalmology Conference 2023

11 April 2023 |
A report covering the NSOC23 event which took place on 25 March 2023.

National Student Ophthalmology Conference 2023

25 March 2023
by Kamal El-Badawi The days of online learning and ‘death by zoom’ have largely come to an end, with conferences transitioning back to face-to-face, allowing attendees to benefit from dynamic communication and networking. However, for students who don’t yet have...

New speaker for the SEE Summit

7 September 2023 | SEE, SEE Summit, Matt Sawyer, ABDO
The Association of British Dispensing Opticians (ABDO) has announced another speaker for the SEE Summit. Former GP Dr Matt Sawyer runs an environmental sustainability consultancy, SEE Sustainability, working to improve human and planetary health.

Exploiting nature’s randomised trials of eye disease

1 December 2022 | | EYE - Glaucoma, EYE - Vitreo-Retinal, EYE - Orbit
Confounding and reverse causation in observational ophthalmic epidemiology Traditional observational studies are inherently limited in establishing a causal effect of an exposure on an outcome of interest. One fundamental limitation is confounding, whereby causation is incorrectly attributed to a third...

OrCam MyEye – innovative sight assistance (Part 2)

4 August 2021 | | EYE - General
Following on from Part 1 of this topic, we will cover the remaining features, pricing and support of the OrCam MyEye. Facial and person identification The MyEye Pro can be taught to recognise up to 150 individuals (or 75 if...

Developing a training model to strengthen diabetic retinopathy screening through a VISION 2020 LINK in India

1 February 2022 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
I. Development of LINK Partnership A VISION 2020 LINK India was established by signing a Memorandum of Understanding (MoU) in 2018 between the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, Frimley Health NHS Foundation Trust and...

Useful, interesting, or maybe both

3 April 2024 | | EYE - General
This column is often, but not always, about ophthalmic tech. This is one of those ‘not always’ editions. Time to share some interesting or useful things from the internet which can help in a number of ways, from preparing presentations...

My Top Five: Key insights from recent research into uveitis in adults

4 December 2025 | | EYE - Vitreo-Retinal
Uveitis, characterised by inflammation of the uvea – the eye’s middle layer comprising the iris, ciliary body, and choroid – remains a leading cause of visual impairment worldwide [1]. It primarily affects adults aged 20–50 years. Untreated uveitis may cause...

DR-NET National DR Workshop in Tanzania: Policy, training and technology

4 August 2025 | | EYE - Imaging, EYE - Vitreo-Retinal
Diabetic retinopathy (DR) is a leading cause of moderate to severe visual impairment (VI) and blindness worldwide, posing a significant public health challenge. As the prevalence of diabetes continues to rise globally, particularly in low- and middle-income countries (LMICs), the...